title: [Outcome of combined phacoemulsification, intraocular lens implantation and viscocanalostomy].
abstract: OBJECTIVE
  To assess the pressure-lowering effect, visual acuity, and intra- and postoperative complications of combined cataract surgery, intraocular lens(IOL) implantation and viscocanalostomy.
  
  
  METHODS
  Combined viscocanalostomy, phacoemulsification, and IOL implantation was performed on 45 eyes, which were followed for more than 6 months after surgery. The average preoperative intraocular pressure(IOP) was 20.2 +/- 3.1(mean +/- standard deviation) mmHg, and the average medication number was 1.7. A prospective study of these cases was performed.
  
  
  RESULTS
  IOP was significantly reduced after surgery, being 13.6 mmHg at 3 months and 15.1 mmHg at 6 months postoperatively. The visual acuity was improved more than 2 lines in 38 eyes. Disruption of Descemet's membrane was noted in 5 eyes and microperforation in 9 eyes as intraoperative complications. Postoperative complications were not vision threatening and included short term hyphema in 34 eyes, fibrin deposition in 5 eyes and IOP spike(> 5 mmHg) in 5 eyes. There were no cases of hypotony, choroidal detachment, or endophthalmitis.
  
  
  CONCLUSIONS
  Combined viscocanalostomy, cataract extraction, and IOL implantation was a safe and efficacious way to reduce IOP.
authors.affiliation: Sensyo-kai Chihara Eye Institute, Japan.
authors.forename: Masami
authors.initials: M
authors.lastname: Park
authors.forename: Masaki
authors.initials: M
authors.lastname: Tanito
authors.forename: Etsuo
authors.initials: E
authors.lastname: Chihara
mesh_terms: D000368:Aged; D002386:Cataract / Q000150:complications / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D019654:Lens Implantation, Intraocular; D008297:Male; D018918:Phacoemulsification; D011446:Prospective Studies; D012599:Sclerostomy / Q000379:methods*; D016896:Treatment Outcome; D014792:Visual Acuity